These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17003088)

  • 1. Randomized study to characterize glycemic control and short-term pulmonary function in patients with type 1 diabetes receiving inhaled human insulin (exubera).
    Norwood P; Dumas R; Cefalu W; Yale JF; England R; Riese R; Teeter J
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2211-4. PubMed ID: 17003088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of long-term immunological and pulmonary safety of inhaled human insulin with up to 24 months of continuous therapy.
    Cefalu WT; Bohannon NJ; Edwin Fineberg S; Teeter JG; Schwartz PF; Reis JM; Krasner AS
    Curr Med Res Opin; 2008 Nov; 24(11):3073-83. PubMed ID: 18828959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of inhaled human insulin (exubera) during discontinuation and readministration of therapy in adults with type 2 diabetes: a 3-year randomized controlled trial.
    Rosenstock J; Cefalu WT; Hollander PA; Klioze SS; Reis J; Duggan WT
    Diabetes Technol Ther; 2009 Nov; 11(11):697-705. PubMed ID: 19905885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of inhaled human insulin (Exubera) compared to subcutaneous insulin in children ages 6 to 11 years with type 1 diabetes mellitus: results of a 3-month, randomized, parallel trial.
    White NH; Quattrin T; St Aubin LB; Duggan WT; England RD; Fryburg JS
    J Pediatr Endocrinol Metab; 2008 Jun; 21(6):555-68. PubMed ID: 18717242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of inhaled human insulin (Exubera) during discontinuation and readministration of therapy in adults with type 1 diabetes: A 3-year randomized controlled trial.
    Skyler JS; Hollander PA; Jovanovic L; Klioze S; Krasner A; Riese RJ; Reis J; Schwartz P; Duggan W;
    Diabetes Res Clin Pract; 2008 Nov; 82(2):238-46. PubMed ID: 18824271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-year pulmonary safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 2 diabetes.
    Rosenstock J; Cefalu WT; Hollander PA; Belanger A; Eliaschewitz FG; Gross JL; Klioze SS; St Aubin LB; Foyt H; Ogawa M; Duggan WT
    Diabetes Care; 2008 Sep; 31(9):1723-8. PubMed ID: 18535196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trough insulin levels in bronchoalveolar lavage following inhaled human insulin (Exubera) in patients with diabetes mellitus.
    Mendivil CO; Teeter JG; Finch GL; Schwartz PF; Riese RJ; Brain JD
    Diabetes Technol Ther; 2012 Jan; 14(1):50-8. PubMed ID: 21875362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-year safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 1 diabetes.
    Skyler JS; Jovanovic L; Klioze S; Reis J; Duggan W;
    Diabetes Care; 2007 Mar; 30(3):579-85. PubMed ID: 17327324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetes: a randomized, controlled trial.
    Rosenstock J; Zinman B; Murphy LJ; Clement SC; Moore P; Bowering CK; Hendler R; Lan SP; Cefalu WT
    Ann Intern Med; 2005 Oct; 143(8):549-58. PubMed ID: 16230721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Inhaled Human Insulin (Exu hera
    White NH; Quattrin T; Aubin LBS; Duggan WT; England RD; Fryburg JS
    J Pediatr Endocrinol Metab; 2020 Oct; 21(6):555-568. PubMed ID: 33600687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Titration of inhaled human insulin (Exubera) in a treat-to-target regimen for patients with type 2 diabetes.
    Hollander PA; Cefalu WT; Mitnick M; Lawrence D; Rosenstock J
    Diabetes Technol Ther; 2010 Mar; 12(3):185-91. PubMed ID: 20151768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-year efficacy and safety of AIR inhaled insulin in patients with type 1 diabetes: An open-label randomized controlled trial.
    Garg SK; Mathieu C; Rais N; Gao H; Tobian JA; Gates JR; Ferguson JA; Webb DM; Berclaz PY
    Diabetes Technol Ther; 2009 Sep; 11 Suppl 2():S5-S16. PubMed ID: 19772449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissociation of lung function changes with humoral immunity during inhaled human insulin therapy.
    Teeter JG; Riese RJ
    Am J Respir Crit Care Med; 2006 Jun; 173(11):1194-200. PubMed ID: 16556690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term tolerability of inhaled human insulin (Exubera) in patients with poorly controlled type 2 diabetes.
    Barnett AH; Lange P; Dreyer M; Serdarevic-Pehar M;
    Int J Clin Pract; 2007 Oct; 61(10):1614-25. PubMed ID: 17877648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trial.
    Quattrin T; Bélanger A; Bohannon NJ; Schwartz SL;
    Diabetes Care; 2004 Nov; 27(11):2622-7. PubMed ID: 15504996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody response to inhaled insulin in patients with type 1 or type 2 diabetes. An analysis of initial phase II and III inhaled insulin (Exubera) trials and a two-year extension trial.
    Fineberg SE; Kawabata T; Finco-Kent D; Liu C; Krasner A
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3287-94. PubMed ID: 15741258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Perspectives of inhaled insulin treatment].
    Chodorowski Z; Sein Anand J
    Przegl Lek; 2007; 64(4-5):365-7. PubMed ID: 17724916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of AIR inhaled insulin compared with subcutaneous insulin in patients having diabetes and asthma: A 12-month, randomized, noninferiority trial.
    Ang E; Lawrence MK; Heilmann CR; Ferguson JA; Tobian JA; Webb DM; Berclaz PY
    Diabetes Technol Ther; 2009 Sep; 11 Suppl 2():S35-44. PubMed ID: 19772447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of inhaled insulin in a basal/bolus insulin regimen in type 1 diabetic subjects: a 6-month, randomized, comparative trial.
    Skyler JS; Weinstock RS; Raskin P; Yale JF; Barrett E; Gerich JE; Gerstein HC;
    Diabetes Care; 2005 Jul; 28(7):1630-5. PubMed ID: 15983312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis: efficacy and safety of inhaled insulin therapy in adults with diabetes mellitus.
    Ceglia L; Lau J; Pittas AG
    Ann Intern Med; 2006 Nov; 145(9):665-75. PubMed ID: 17088580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.